Antibiotics: Why they fail in patients who are critically ill

Critical Care Nursing Quarterly

Volumn 20, Issue 3, 1997, Pages 60-68

  Bamberger, David M ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abscesses; Antimicrobial combinations; Antimicrobial efficacy; Bactericidal activity; Foreign body infections; Microbial resistance; Pharmacodynamics; Pharmacokinetics

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; TOXIN;

ABSCESS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERICIDAL ACTIVITY; CRITICAL ILLNESS; DRUG PENETRATION; DRUG PROTEIN BINDING; FOREIGN BODY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; REVIEW; TREATMENT FAILURE;

EID: 0030723422     PISSN: 08879303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002727-199711000-00007     Document Type: Review

References (21)

1. Tillotson JR, Finland M. Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia. J Infect Dis. 1969;119:597-624.
2. Moore RD, Smith CR, Lietman PS. Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med. 1984;77:657-662.
3. Viladrich PF, Gudiol F, Linares J, et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother. 1991;35:2467-2472.
4. Stratton CW. In vitro testing: correlations between bacterial susceptibility, body fluid levels and effectiveness of antibacterial therapy. In: Lorian V, ed. Antibiotics in Laboratory Medicine. 3rd ed. Baltimore, Md: Williams & Wilkins; 1991.
5. Beam TR. Sequestration of staphylococci at an inaccessible focus. Lancet. 1979;ii:227-228.
6. Johnson CC. In vitro testing: correlations between bacterial susceptibility, body fluid levels and effectiveness of antibacterial therapy. In: Lorian V, ed. Antibiotics in Laboratory Medicine. 4th ed. Baltimore, Md: Williams & Wilkins; 1996.
7. DiNubile MJ. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users. Ann Intern Med. 1994;121:873-876.
8. Eliopoulos GM, Moellering RC. Antimicrobial combinations. In: Lorian V, ed. Antibiotics in Laboratory Medicine. 4th ed. Baltimore, Md: Williams & Wilkins; 1996.
9. Lepper MH, Dowling HF. Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin. Arch Intern Med. 1951;88:489-494.
10. Sanders CC, Thomson KS, Bradford PA. Problems with detection of β-lactam resistance among nonfastidious gram-negative bacilli. Infect Dis Clin North Am. 1993;7:411-424.
11. Chow JW, Fine MJ, Shlaes DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med. 1991;115:585-590.
12. Livermore DM, Williams JD. β-lactams: mode of action and mechanisms of bacterial resistance. In: Lorian V, ed. Antibiotics in Laboratory Medicine. 4th ed. Baltimore. Md: Williams & Wilkins; 1996.
13. McCabe WR, Treadwell TL. In vitro susceptibility tests: correlations between sensitivity testing and clinical outcome in infected patients. In: Lorian V, ed. Antibiotics in Laboratory Medicine. 2nd ed. Baltimore, Md: Williams & Wilkins; 1986.
14. Bamberger DM. Outcome of medical treatment of bacterial abscesses without therapeutic drainage: review of cases reported in the literature. Clin Infect Dis. 1996;23:592-603.
15. Stevens DL, Yan S, Bryant AE. Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis. 1993;167:1401-1405.
16. Bamberger DM, Herndon BL, Suvarna PR. The effect of zinc on microbial growth and bacterial killing by cefazolin in a Staphylococcus aureus abscess milieu. J Infect Dis. 1993;168:893-896.
17. Zimmerli W, Frei R, Widmer AF, Rajacic Z. Microbiological test to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother. 1994;33:959-967.
18. Maki DG. Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention, and management. In: Bisno AL, Waldvogel FA, eds. Infections Associated with Indwelling Medical Devices. 2nd ed. Washington, DC. American Society for Microbiology; 1994.
19. Karchmer AW, Gibbons GW. Infections of prosthetic heart valves and vascular grafts. In: Bisno AL, Waldvogel FA, eds. Infections Associated with Indwelling Medical Devices. 2nd ed. Washington, DC. American Society for Microbiology; 1994.
20. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother. 1993;37:1214-1218.
21. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis. 1992;14:1251-1253.